Welcome to AstraZeneca Medicines
Whether you need to cross-check an indication, help a patient understand their condition, or catch up on a recent meeting, you'll find the right information fast, letting you return to your number one priority: helping your patients. AstraZeneca Medicines is an online resource for Healthcare Professionals.
Cardiovascular
Cardiovascular
Diabetes
Diabetes
Oncology
Oncology
Haematology
Haematology
Respiratory
Respiratory
- Brilique (ticagrelor) - Great Britain Prescribing Information
- Brilique (ticagrelor) - Northern Ireland Prescribing Information
- Bydureon BCise (exenatide) – Great Britain Prescribing Information
- Bydureon BCise (exenatide) – Northern Ireland Prescribing Information
- Calquence ▼ (acalabrutinib) – Great Britain Prescribing Information
- Calquence ▼ (acalabrutinib) – Nothern Ireland Prescribing Information
- Daxas ▼ (roflumilast) Prescribing Information
- Fasenra (benralizumab) Great Britain Prescribing Information
- Fasenra (benralizumab) Northern Ireland Prescribing Information
- Forxiga (dapagliflozin) - Great Britain Prescribing Information
- Forxiga (dapagliflozin) - Northern Ireland Prescribing Information
- IMFINZI▼(durvalumab) - Great Britain Prescribing Information
- IMFINZI▼(durvalumab) - Northern Ireland Prescribing Information
- Iressa (ticagrelor) - Great Britain Prescribing Information
- Iressa (ticagrelor) - Northern Ireland Prescribing Information
- Lokelma (Sodium Zirconium Cyclosilicate) - Great Britain Prescribing Information
- Lokelma (Sodium Zirconium Cyclosilicate) - Northern Ireland Prescribing Information
- Lynparza (olaparib) – (tablets) breast cancer – Great Britain Prescribing Information
- Lynparza (olaparib) – (tablets) breast cancer – Northern Ireland Prescribing Information
- Lynparza (olaparib) - (tablets) ovarian cancer - Great Britain Prescribing information
- Lynparza (olaparib) - (tablets) ovarian cancer - Northern Ireland Prescribing information
- Lynparza (olaparib) - (tablets) prostate cancer - Great Britain Prescribing information
- Lynparza (olaparib) - (tablets) prostate cancer - Northern Ireland Prescribing information
- Ondexxya ▼ (andexanet alfa) - Great Britain Prescribing Information
- Ondexxya ▼ (andexanet alfa) - Northern Ireland Prescribing Information
- Onglyza (saxagliptin) Prescribing Information
- QTERN (saxagliptin/ dapagliflozin) - Great Britain Prescribing Information
- QTERN (saxagliptin/ dapagliflozin) - Northern Ireland Prescribing Information
- Symbicort (budesonide/formoterol) Asthma Prescribing Information
- Symbicort (budesonide/formoterol) COPD Prescribing Information
- Tagrisso ▼ (osimertinib) - Great Britain Prescribing Information
- Tagrisso ▼ (osimertinib) - Northern Ireland Prescribing Information
- Tezspire ▼ (Tezepelumab) Great Britain Prescribing Information
- Tezspire ▼ (Tezepelumab) Northern Ireland Prescribing Information
- Xigduo (dapagliflozin and metformin HCI) – Great Britain Prescribing Information
- Xigduo (dapagliflozin and metformin HCI) – Northern Ireland Prescribing Information
- Zoladex (goserelin) Prescribing Information
AstraZeneca are committed to meeting patient needs through innovative medicines and clinical excellence, we conduct clinical trials to help determine the safety and efficacy of a new medicine. In line with our Group Corporate Responsibility Policy on transparency, we are committed to open communication of information on AstraZeneca's clinical trials. We provide details of new and ongoing clinical trials sponsored by AstraZeneca. Visit the AstraZeneca clinical trials website at astrazenecaclinicaltrials.com.
For medical enquiries about our products (including questions on how to take our medicines, to report a side effect or make a complaint regarding one of our medicines).
UK based Medical Information team
Call: 0800 783 0033.
Lines are open from Monday-Friday, 9am - 5pm. Outside of these hours and on bank holidays, an out of hours service is available to assist with urgent enquiries.
GB-43257 | DOP August 2023